Pharmacokinetics and Safety Study of Single and Multiple Oral Doses Prodarsanâ„¢ in Patients With Cockayne Syndrome
| Status: | Archived |
|---|---|
| Conditions: | Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | June 2010 |
| End Date: | December 2010 |
A Phase I/II Crossover Study To Evaluate and Compare the Pharmacokinetics of a Single IV Dose of D-Mannitol (Osmitrol®10%) to Single and Multiple, Escalating Doses of Liquid, Oral Prodarsan™ in Patients With Cockayne Syndrome
This study is to compare the exposure of orally administered Prodarsan to the intravenous
dosed Osmitrol (10% solution) in Cockayne Syndrome (CS) patients. Also the pharmacokinetics
of single and multiple orally dosed Prodarsan will be evaluated and compared to intravenous
dose of Osmitrol in CS patients.
We found this trial at
1
site
Children's Hospital - Boston Boston Children's Hospital is a 395-bed comprehensive center for pediatric health...
Click here to add this to my saved trials
